Skip to content

In the BioHarmony Drug Report Database

Almotriptan

Axert (almotriptan) is a small molecule pharmaceutical. Almotriptan was first approved as Axert on 2001-05-07. It is used to treat migraine disorders in the USA. It is known to target 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D.
Trade Name Axert
Common Name Almotriptan
Indication migraine disorders
Drug Class Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives
Almotriptan
Get full access now